Submissions from 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma., P Grover, S N Lo, I Li, A M J Kuijpers, F Kreidieh, A Williamson, T Amaral, F Dimitriou, J Placzke, K Olino, M G Vitale, P Saiag, R Gutzmer, C Allayous, R Olofsson Bagge, J Mattsson, N Asher, T J Carter, T M Meniawy, A R Lawless, J A Czapla, L Warburton, C Gaudy-Marqueste, J J Grob, R G Collins, E Zhang, J I Kessels, B Neyns, I Mehmi, O Hamid, M Julve, A J S Furness, K A Margolin, Shaked Lev-Ari, J M Ressler, W Haque, M A Khattak, A Wicky, R Roberts-Thomson, A Arance, G Warrier, M D Schollenberger, P Parente, E Chatziioannou, E J Lipson, O Michielin, J S Weber, C Hoeller, J Larkin, M B Atkins, R Essner, D B Johnson, R J Sullivan, P Nathan, J Schachter, C Lebbe, P A Ascierto, H Kluger, P Rutkowski, R Dummer, C Garbe, P C Lorigan, E Burton, H A Tawbi, J Haanen, M S Carlino, A M Menzies, and G V Long
A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEP., J Michael Guenther, Andrew Ward, Brian J Martin, Mark Cripe, Timothy Beard, Oliver Wisco, Rohit Sharma, Stanley P Leong, Richard Essner, Joseph I Clark, John Hamner, Brenda Sickle-Santanello, and Maki Yamamoto
TGFβ limits proximal CD8+ TCR signaling via PTPN22 following strong and moderate agonism., Andrew J Gunderson, Kelley R Jordan, Tomoko Yamazaki, Hans-Peter Raué, Gwen Kramer, Nathaniel E Fox, Mark K Slifka, Michael J. Gough, Marka R Crittenden, and Kristina H Young
Longitudinal retrospective study of real-world adherence to colorectal cancer screening before and after the COVID-19 pandemic in the USA., Harsh Gupta, Robyn Ann Husa, Staci J Wendt, Ann Vita, Claire Boone, Jessica B Weiss, and Anton J Bilchik
Dostarlimab and niraparib in primary advanced ovarian cancer., A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, F Montestruc, A Redondo, M R Mirza, D Cibula, T-E Ciuleanu, L Gilbert, R Eitan, F Zagouri, S Pignata, R Glasspool, J Pfisterer, R Phaëton, C K Anderson, M Rodrigues, L Gaba, E Bakirtzi, J M Fauci, E Kalbacher, F B Musa, S Gorman, L R Duska, L Gladieff, P Braly, F Joly, J Thomes Pepin, I Ray-Coquard, and K N Moore
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers., Arielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe, Chad Livasy, James T Symanowski, Meghan R Steiner, Irene M Kang, Dave S B Hoon, Philip Walker, George W Sledge, Milan Radovich, Paula R Pohlmann, Sandra M Swain, and Antoinette R Tan
Association of baseline ctDNA EGFR mutation detection with clinical outcome in the phase II RAMOSE trial assessing ramucirumab plus osimertinib versus osimertinib in EGFR mutant non-small cell lung cancer, S Heeke, Rachel Sanborn, and See full list of authors in comments
Implementation of a Traceback Testing Program for Ovarian Cancer: Findings from the FACTS Study., Nora B Henrikson, M Cabell Jonas, Paula R Blasi, Adam H Buchanan, Pim Suwannarat, Kathleen Leppig, Aaron Scrol, Tracey Leitzel, Adrienne N Deneal, Daniela Canedo, Arvind Ramaprasan, Sundeep S Basra, Jennifer Brown, Marilyn Odums, Yirui Hu, Katrina M Romagnoli, Estella Khieu, Elsa Balton, Saumya Patel, Muki Kunnmann, Dina Hassen, Jing Hao, Meredith Lewis, Rachel Schwiter, Jessica Goehringer, Heather M Ramey, Shanshan Gustafson, Katrina Hsieh, Ilene Ladd, and Alanna K Rahm
Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis., Jaime O Herrera-Caceres, Marian Wettstein, Surena F Matin, Craig Labbate, Aaron Potretzke, Rodrigo Rodriguez, Nirmish Singla, Maximilian Pallauf, William Huang, Shavy Nagpal, Nir Kleinmann, Asaf Shvero, Alexander Small, Benjamin Green, Jennifer Linehan, Jane Choe, Ojas Shah, Arun Rai, Hristos Kaimakliotis, Isamu Tachibana, David Canes, Aaron Perecman, and Jay D Raman
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering., Nisha Holay, Rashi Yadav, Sae Jeong Ahn, Melissa Kasiewicz, Anya Polovina, Annah S Rolig, Thi Staebler, Bryan Becklund, Noah D Simons, Yoshinobu Koguchi, Brendan P Eckelman, Yaiza Diaz de Durana, and William L. Redmond
Exploring decisional control preferences in older patients with cancer and their caregivers., Sofiia Hryniv, Elizabeth Gilbride, William Consagra, Supriya Mohile, Sule Yilmaz, Kaitlin Kyi, Sindhuja Kadambi, Marielle Jensen-Battaglia, Nikesha Gilmore, Mary Whitehead, Jamil Khatri, Fadi S Braiteh, Alison Conlin, Kah Poh Loh, and Allison Magnuson
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis., Amy H Huang, Gin Yi Lee, Chuan Angel Lu, Ibrahim Halil Sahin, Gentry T King, Rachael A Safyan, Stacey A Cohen, David B Zhen, Veena Shankaran, William P Harris, Andrew L Coveler, Jyoti Malhotra, Victoria E Forbes, Philip J Gold, E Gabriela Chiorean, and Ronan W Hsieh
The end of the genetic paradigm of cancer., Sui Huang, Ana M Soto, and Carlos Sonnenschein
A single-center experience of oncology rehabilitation to facilitate cardiopulmonary fitness recovery among breast cancer patients receiving chemotherapy, Mary Imboden, Hsin-Fang Li, E Koltner, Corrin Murphy, David B. Page, and Michael Layoun
Access to GLP-1s: Where Do Employers Fit in?, Mary T Imboden
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma., Jana Ivanidze, Kellen Vo Vu, Rongwei Fu, Andrew Brandmaier, Laszlo Szidonya, Gagandeep Choudhary, Jay Starkey, Tony J Wang, Michael Sisti, L Guy McKhann, Sushant Puri, Marcus Konner, Michelle Roytman, Eaton Lin, Andrew Kuhn, Joseph R Osborne, Philip E Stieg, Kathryn Beal, Rohan R Ramakrishna, Gagandeep Singh, Angela Lignelli-Dipple, Mikhail Doubrovin, Anh Huan Vo, Mary Welch, Fabio Iwamoto, Aya Haggiagi, Laura Donovan, Maria Diaz, Brian Gill, Benjamin Liechty, David J Pisapia, Josh Walker, Rajiv S Magge, Matthew Wood, Valentina Marulanda Corzo, Olabisi R Sanusi, Ahmed Raslan, Aclan Dogan, Stephen Bowden, Sadek A Nehmeh, Joshua Nickerson, Nadine Mallak, Amber Ruiz, Prakash Ambady, Ali Nabavizadeh, and Ramon F Barajas
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma., Nitin Jain, Toby A Eyre, Katherine B Winfree, Naleen Raj Bhandari, Manoj Khanal, Tomoko Sugihara, Yongmei Chen, Paolo Abada, and Krish Patel
Pretraining Patient Foundation Models on Multimodal Patient Journeys, Daniel P Jeong, Suhana Bedi, Cliff Wong, Sheng Zhang, Jeya Maria Jose Valanarasu, Qianchu Liu, Reuben Tan, Zelalem Gero, Jaspreet Baga, Juan Manuel Zambrano Chaves, Naoto Usuyama, Hanwen Xu, Roshanthi Weerasinghe, Rom Leidner, Brian D. Piening, Carlo Bifulco, Tristan Naumann, and Hoifung Poon
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium., Komal Jhaveri, Carey K Anders, Aditya Bardia, Manali Bhave, A Jo Chien, Ian Krop, Tiffany A Traina, Yara Abdou, Reva Basho, Alison K Conlin, Francisco J Esteva, Kevin R Fox, Vijayakrishna Gadi, Peter A Kaufman, Anya Litvak, Cynthia X Ma, Eleftherios P Mamounas, Heather McArthur, Kelly McCann, Zahi Mitri, Rebecca Shatsky, Melinda Telli, Mylin A Torres, and Kevin Kalinsky
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer., Melissa L Johnson, Egbert F Smit, Enriqueta Felip, Suresh S Ramalingam, Myung-Ju Ahn, Anne Tsao, Bruce E Johnson, Michael Offin, Maen Hussein, Ibiayi Dagogo-Jack, Jonathan W Goldman, Jeffrey M Clarke, Marcelo V Negrao, Rachel E Sanborn, Daniel Morgensztern, Tiziana Usari, Keith Wilner, Linh Alejandro, Nada Rifi, Xiaosong Zhang, and Gregory J Riely
Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy., Mackenzie Jones, Zahraa W Alsafwani, Javier I J Orozco, Subodh M Lele, Mohd Wasim Nasser, Surinder K Batra, and Juan A Santamaria-Barria
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review., Tiffany M Juarez, Jaya M Gill, Boris R Minev, Akanksha Sharma, and Santosh Kesari
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review., Tiffany M Juarez, Jaya M Gill, Boris R Minev, Akanksha Sharma, and Santosh Kesari
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence., Rafi Kabarriti, Shane Lloyd, James Jabalee, Catherine Del Vecchio Fitz, Randa Tao, Tyler Slater, Corbin Jacobs, Sean Inocencio, Michael Rutenberg, Chance Matthiesen, Kasha Neff, Gene-Fu Liu, Tiffany M Juarez, and Stanley L Liauw
Epigenetic Regulation of OLIG2 in Glioblastoma: Mechanisms and Therapeutic Targets to Combat Treatment Resistance., Sanya Kapoor, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Efficacy of Endoscopic Full Thickness Resection Using the Full-Thickness Resection Device for Submucosal Invasive Colorectal Cancer: The First United States Multicenter Experience., Rahul Karna, Syed Kashif Mahmood, Jennifer Phan, Sumant Inamdar, Antonio Mendoza Ladd, Veeral M Oza, Mohit Girotra, Harshit Khara, Natalie Wilson, Nabeel Azeem, and Mohammad Bilal
Radiation therapy causes a STING and MyD88-independent upregulation of CD80 and CD86 in macrophages and monocytes that limits tumor control., Aanchal Preet Kaur, Jason R Baird, Alejandro F Alice, Gwen Kramer, David Friedman, Eva Moran, Marka R Crittenden, and Michael J. Gough
Commentary: Molecular responses in pig heart to human xenotransplantation unveiled by longitudinal multi-omic profiling., Brendan J Keating, Eloi Schmauch, Michael P Snyder, Jennifer D Motter, and Brian D. Piening
Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program., Grace Keegan, Joseph Ravenell, Angelena Crown, Charles DiMaggio, and Kathie-Ann Joseph
Metastatic Melanoma Outcomes and the Evolving Role of Surgery in the Immunotherapy Era., Hilary R Keller, Douglas A Hanes, Jillian K McCabe, Danny Lascano, Paul Shin, Melanie Goldfarb, and Richard Essner
Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy., Mohamed A Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, Jennifer R Brown, Mazyar Shadman, Farrukh T Awan, Saad S Kenderian, Tanya Siddiqi, Jeremy S Abramson, Taha Al-Juhaishi, Danielle M Brander, Catherine C Coombs, Richard R Furman, Nitin Jain, Nadia Khan, Nakhle S Saba, Jennifer M Collins, Amer Beitinjaneh, Deborah M Stephens, Jennifer Woyach, and Mehdi Hamadani
Machine Learning Model Predictors of Intrapleural Tissue Plasminogen Activator and DNase Failure in Pleural Infection: A Multicenter Study., Danai Khemasuwan, Candice Wilshire, Chakravarthy Reddy, Christopher Gilbert, Jed Gorden, Akshu Balwan, Trinidad M Sanchez, Billie Bixby, Jeffrey S Sorensen, and Samira Shojaee
Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant, and Therapeutic Target?, Eugene Y Kim, Joyce Abides, Chandler R Keller, Steve R Martinez, and Weimin Li
Cancer care disparities among patients with limited English proficiency: challenges and strategies for equity., Hye Sung Kim, Carly Irwin, Arjun S Ulag, and Siddhartha Devarakonda
Impact of Patient Positioning and Endotracheal Intubation During ERCP: Insights from a Large Database., Divyanshoo R Kohli, Nishant Puri, Douglas A Hanes, Jack Brandabur, and Wichit Srikureja
Correction: CITEViz: interactively classify cell populations in CITE-Seq via a flow cytometry-like gating workflow using R-Shiny., Garth L Kong, Thai T Nguyen, Wesley K Rosales, Anjali D Panikar, John H W Cheney, Theresa A Lusardi, William M Yashar, Brittany M Curtiss, Sarah A Carratt, Theodore P Braun, and Julia E Maxson
Endothelial cells as targets of immune checkpoint blockade., Alan J Korman, Matthew H Taylor, and F Stephen Hodi
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study., Matthew G Krebs, Byoung Chul Cho, Sandrine Hiret, Ji-Youn Han, Ki Hyeong Lee, Casilda Llácer Pérez, Filippo De Braud, Eric B Haura, Rachel E Sanborn, James Chih-Hsin Yang, Catherine A Shu, Koichi Goto, Makoto Nishio, Jun Zhao, Zhijie Wang, Pascale Tomasini, Enriqueta Felip, Jonathan W Goldman, Sai-Hong Ignatius Ou, Michael Boyer, Grace Gao, Siyang Qu, Joshua C Curtin, Xuesong Lyu, Robert W Schnepp, Priya Kim, Meena Thayu, Roland E Knoblauch, Patricia Lorenzini, Mahadi Baig, Alexander I Spira, and Natasha B Leighl
Long-term oncologic outcomes and complications of robot-assisted radical cystectomy for the treatment of urothelial carcinoma of the bladder., Daniel J Lama, Oluwatimilehin Okunowo, Jonathan Yamzon, Ali-Asghar Zhumkhawala, Timothy G Wilson, Clayton S Lau, Bertram E Yuh, and Kevin G Chan
Low rates of cardiotoxicity during HER2-directed antibody therapy for breast cancer across a large, Western US hospital system, Michael Layoun; David B Page; Hsin-Fang Li; Cameron Smith, DO, MPH; E Koltner; Mary Imboden; Zachary Taylor; and Kateri Spinelli
Lessons learned in migrating from one commercial genetics clinical decision-making tool to another: Assessment of data integrity and utilization., Calvin Le, Kevin Tatunay, Wayne Liu, Haibo Lu, Nicole-Ann Rodis, Thomas Nam, Mercy Y Laurino, and Marianne E Dubard-Gault
Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses., Hans C Lee, Jeffrey A Zonder, Madhav V Dhodapkar, Sundar Jagannath, James E Hoffman, Attaya Suvannasankha, Mansi R Shah, Suzanne Lentzsch, Rachid Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez-Lopez, Michelle DeVeaux, Tito Roccia, Dhruti Chokshi, Megan Seraphin, Kate Knorr, Anita Boyapati, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn S Kroog, Naresh Bumma, and Joshua Richter
Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer., Kyle Lee, Angela Pallesi, Betsy Valdez, Douglas A Hanes, Estela Samuels, Stacey Stern, Nicketti Handy, Crystal E Fancher, Javier I Orozco, and Janie Grumley
3D Brain Vascular Niche Model Captures Glioblastoma Infiltration, Dormancy, and Gene Signatures., Vivian K Lee, Rut Tejero, Nathaniel Silvia, Anirudh Sattiraju, Aarthi Ramakrishnan, Li Shen, Alexandre Wojcinski, Santosh Kesari, Roland H Friedel, Hongyan Zou, and Guohao Dai
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve, Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn, Catherine A Shu, Chul Kim, Mary Jo Fidler, Richard Hall, Yasir Y Elamin, Janet Tu, George Blumenschein, Jianjun Zhang, Don Gibbons, Carl Gay, Nisha A Mohindra, Young Chae, Yanis Boumber, Joshua Sabari, Rafael Santana-Davila, Shane Rogosin, Benjamin Herzberg, Ben Creelan, Bruna Pellini, Tawee Tanvetyanon, Simon Heeke, Mike Hernandez, Jhanelle E Gray, Andreas Saltos, and John V Heymach
Alterations of the composition and spatial organization of the microenvironment following non-dysplastic Barrett's esophagus through progression to cancer., Meng-Lay Lin, John W Hickey, Adam Passman, Emanuela Carlotti, Shruthi Devkumar, Yannick H Derwa, Joanne ChinAleong, Richard J Hackett, James Evans, Veena Sangwan, Marco R Novelli, Manuel Rodriguez Justo, Nicholas A Wright, Marnix Jansen, Tim J Underwood, Sui Huang, Philippe Gascard, Mairi H McLean, Christian M Schürch, Thea D Tlsty, Lorenzo Ferri, Garry P Nolan, and Stuart A C McDonald
Asia's emergence in cancer immunotherapy: challenges and opportunities., Yan Li, Joe Yeong, Bernard A Fox, and Cheng Sun
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial., Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L Siu, Patricia LoRusso, Claire F Friedman, Ani S Balmanoukian, Michael Gordon, Jeffrey Yachnin, Sylvie Rottey, Ioannis Karydis, George A Fisher, Marcus Schmidt, Martin Schuler, Ryan J Sullivan, Howard A Burris, Vladimir Galvao, Brian S Henick, Luc Dirix, Dirk Jaeger, Patrick A Ott, Kit Man Wong, Guy Jerusalem, Aglaia Schiza, Lawrence Fong, Neeltje Steeghs, Rom Leidner, Achim Rittmeyer, Scott A Laurie, Eelke Gort, Raid Aljumaily, Ignacio Melero, Rachel L Sabado, Ina Rhee, Michael R Mancuso, Lars Muller, Gregg D Fine, Mahesh Yadav, Leesun Kim, Vincent J P Leveque, Alberto Robert, Martine Darwish, Ting Qi, Jiawen Zhu, Jingbin Zhang, Patrick Twomey, Gautham K Rao, Donald W Low, Chris Petry, Amy A Lo, Jill M Schartner, Lélia Delamarre, Ira Mellman, Martin Löwer, Felicitas Müller, Evelyna Derhovanessian, Andrea Cortini, Luisa Manning, Daniel Maurus, Sebastian Brachtendorf, Verena Lörks, Tana Omokoko, Eva Godehardt, Dirk Becker, Christine Hawner, Christine Wallrapp, Christian Albrecht, Christoph Kröner, Arbel D Tadmor, Jan Diekmann, Mathias Vormehr, Anette Jork, Anna Paruzynski, Maren Lang, Jonathon Blake, Oliver Hennig, Andreas N Kuhn, Ugur Sahin, Özlem Türeci, and D Ross Camidge
Updates in Management of Locally and Regionally Advanced Basal Cell Carcinoma., Kristel Lourdault, Brett Crosby, Jillian McCabe, and Richard Essner
A pilot survey into the landscape of neuro-oncology care in the community., Christine Lu-Emerson, Sajeel Chowdhary, Rupesh Kotecha, Akanksha Sharma, Yazmin Odia, Brian Vaillant, Charles Redfern, Aaron Mammoser, Kent Shih, Santosh Kesari, Richard Peterson, Bret Friday, W Jeffery Edenfield, Sebastian Koga, James Snyder, Jerry Jaboin, Isaac Melguizo-Gavilanes, Melissa McCabe, Michael Humeniuk, Prakash Ambady, and Erin Dunbar
In Regard to Aly et al., Join Y Luh
Telehealth in Radiation Oncology: Time to Refine, Not Just Expand., Join Y Luh
Estimation of the value-based price of a blood test for Alzheimer's disease pathology in primary and specialty care in the U.S., Soeren Mattke, Jiahe Chen, Mark Hanson, Kim G Johnson, Cara Leahy, David A Merrill, Victoria Shada, and Jorge G Ruiz
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence., Francesco Mazziotta, Lauren E Martin, Daniel N Egan, Merav Bar, Sinéad Kinsella, Kelly G Paulson, Valentin Voillet, Miranda C Lahman, Daniel Hunter, Thomas M Schmitt, Natalie Duerkopp, Cecilia C S Yeung, Tzu-Hao Tang, Raphael Gottardo, Yuta Asano, Elise C Wilcox, Bo Lee, Tianzi Zhang, Paolo Lopedote, Livius Penter, Catherine J Wu, Filippo Milano, Philip D Greenberg, and Aude G Chapuis
Implementation of a lisocabtagene maraleucel chimeric antigen receptor T-cell therapy outpatient monitoring program: Multicenter nursing/advanced practice provider perspectives., Nicole McEntee, Jacqueline Manago, ChiaChun Lu, and Lucy Holmes
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry., Margaret F Meagher, Clara Cerrato, Mimi V Nguyen, Riccardo Autorino, Reza Mehrazin, Daniel Eun, Vitaly Margulis, Robert Uzzo, James R Porter, Chandru Sundaram, Firas Abdollah, Alexandre Mottrie, Andrea Minervini, Alessandro Antonelli, Maria A Cerruto, Matteo Ferro, Hooman Djaladat, Zhenjie Wu, Alireza Ghoreifi, Kevin Hakimi, Cesare Saitta, Ava Saidian, Arman Walia, Savio D Pandolfo, Riccardo Tellini, Alessandro Veccia, Elio Mazzone, Koon Rha, Mark Gonzalgo, and Ithaar H Derweesh
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors., Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, Diego Villa, Jun Zhang, Jennifer Friedmann, Fengting Yan, Mark A Socinski, John Sarantopoulos, Luis E Raez, Quincy S Chu, Maxime Chénard-Poirier, Manash S Chatterjee, Hong Ren, Qi Liu, Douglas A Levine, and Komal L Jhaveri
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors., Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, Glenn J Hanna, Douglas E Laux, Theresa M Medina, George Ansstas, Adil Daud, Ciara M Kelly, Steven J O'Day, Cesar A Perez, Michael K Wong, Philip A Friedlander, Timothy S Kristedja, Melissa A Burgess, C Lance Cowey, Brent A Hanks, Ryan M Weight, Weston L Daniel, Douglas E Feltner, Scott Mix, Laurel Sindelar, Alice S Bexon, Martin F Bexon, Robert E Michel, and Shailender Bhatia
A fibroblast-centric network drives cold fibrosis in the tumor microenvironment of lung squamous cell carcinoma., Shoval Miyara, Shachaf Frenkel, Avi Mayo, Philippe Gascard, Michael Strasser, David Gibbs, Eviatar Weizman, Itay Ben Shalom, Yaniv Stein, Deng Pan, Joseph A Caruso, Veena Sangwan, Nicholas Bertos, Julie Berube, Sophie Camilleri-Broet, Spyridon Oikonomopoulos, Haig Djambazian, Kfir Baruch Umansky, Jacob Elkahal, Shimrit Mayer, Pierre-Olivier Fiset, Jiannis Ragoussis, Miri Adler, Eldad Tzahor, Sui Huang, Lorenzo Ferri, Thea D Tlsty, Ruth Scherz-Shouval, and Uri Alon
Characterization of pritumumab in murine models and primate safety study., Avani A Mody, Rajesh Mukthavaram, Pengfei Jiang, Kishore Gangangari, Nagavarakishore Pillarsetty, Pranav R Kesari, Vijay Padul, Sneha L Kesari, Elnaz Rahbarlayegh, Mark C Glassy, and Santosh Kesari
Patterns of Clinical Trial Enrollment for Pediatric Patients With Hepatoblastoma and Wilms Tumor: A Report From the Children's Oncology Group., Pablo S Monterroso, Sarah Lucht, Jeannette M Sample, Angela D Trobaugh-Lotrario, Helen M Parsons, Lucie M Turcotte, David Van Riper, Jenny N Poynter, and Erin L Marcotte
An Atypical Presentation of Metastatic Gastric Adenocarcinoma Due to Pulmonary Lymphangitic Carcinomatosis, Matthew Moritz, MD and Omar Pandhair, MD
Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery., Astrid D Morris, Douglas Hanes, and Henry G Kaplan
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation., Zachary S Morris, Sandra Demaria, Arta M Monjazeb, Silvia C Formenti, Ralph R Weichselbaum, James Welsh, Heiko Enderling, Jonathan D Schoenfeld, Joshua D Brody, Heather M McGee, Michele Mondini, Michael S Kent, Kristina H Young, Lorenzo Galluzzi, Sana D Karam, Willemijn S M E Theelen, Joe Y Chang, Mai Anh Huynh, Adi Daib, Sean Pitroda, Caroline Chung, Raphael Serre, Clemens Grassberger, Jie Deng, Quaovi H Sodji, Anthony T Nguyen, Ravi B Patel, Simone Krebs, Anusha Kalbasi, Caroline Kerr, Claire Vanpouille-Box, Logan Vick, Todd A Aguilera, Irene M Ong, Fernanda Herrera, Hari Menon, DeeDee Smart, Jalal Ahmed, Robyn D Gartrell, Christina L Roland, Fatemeh Fekrmandi, Binita Chakraborty, Eric H Bent, Tracy J Berg, Alan Hutson, Samir Khleif, Andrew G Sikora, and Lawrence Fong
Team-Based Versus Technology-Based Supportive Cancer Care: A Mixed Methods Study of Multi-Site Implementation., Sacha Moufarrej, Emily H Wood, Niharika Dixit, Raymond Liu, Lori Sakoda, Finly Zachariah, Gabrielle Rocque, M Zachary Koontz, David J Park, Daniel Kwon, Jennifer Y Pierce, Sangeeta Aggarwal, Rebbeca Sudore, Tumaini Coker, and Manali I Patel
Ivermectin and gynecologic cancer: What's the data?, Vaidehi Mujumdar, Marilyn Huang, Lindsey Chippendale Smith, and Fernanda Musa
Individualized dynamic risk assessment and treatment selection for multiple myeloma., Carl Murie, Serdar Turkarslan, Anoop P Patel, David G Coffey, Pamela S Becker, and Nitin S Baliga
In-depth analysis of endogenous retrovirus expression in glioblastoma., Daniel A Murimi-Worstell, Irene B Murimi-Worstell, Farrah M Roy, Aidan Burn, Michael Freeman, Ralph B Puchalski, and John M Coffin
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025., Fernanda Musa, Kathleen N Moore, Vivek Podder, and Brian M Slomovitz
Multiomic Characterization of, Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, Sahar F Bannoura, Chul Kim, Andrew Elliott, Balazs Halmos, Dave Hoon, Sourat Darabi, Ammar Sukari, Milan Radovich, Emil Lou, George Sledge, Wafik El-Deiry, Mohammed Najeeb Al-Hallak, Boris C Pasche, and Asfar S Azmi
Ubiquitin E3 ligase KPC1 governs mesenchymal metastatic melanoma reprogramming via proteasomal degradation of ZEB1., Yusuke Nakano, Matias A Bustos, Kelly Chong, Yoshinori Hayashi, Aaron Ciechanover, and Dave S B Hoon
Integrated Antigenic and Nucleic Acid Detection in Single Virions and Extracellular Vesicles with Viral Content., Kim Truc Nguyen, Xilal Y Rima, Luong T H Nguyen, Xinyu Wang, Kwang Joo Kwak, Min Jin Yoon, Hong Li, Chi-Ling Chiang, Jacob Doon-Ralls, Kelsey Scherler, Shannon Fallen, Stephanie L Godfrey, Julie A Wallick, Setty M Magaña, Andre F Palmer, Inyoul Lee, Christopher C. Nunn, Kimberly M Reeves, Henry G Kaplan, Jason D Goldman, James R Heath, Kai Wang, Preeti Pancholi, L James Lee, and Eduardo Reátegui
Accuracy of Falls Screening Tools in Adult Patients With Cancer: A Systematic Review., Kelli A Nielsen, Michael Foley, Earllaine Croarkin, Patricia Runde, Stephanie Prinster, and Laura S Gilchrist
Comparative microRNA signatures based on liquid biopsy to identify lymph node metastasis in T1 colorectal cancer patients undergoing upfront surgery or endoscopic resection., Kazuaki Okamoto, Hiroaki Nozawa, Tsuyoshi Ozawa, Yoko Yamamoto, Yuichiro Yokoyama, Shigenobu Emoto, Koji Murono, Kazuhito Sasaki, Mitsuhiro Fujishiro, and Soichiro Ishihara
Genomic determinants of therapy response in ETV6::RUNX1 leukemia., Laura Oksa, Sanni Moisio, Khurram Maqbool, Roger Kramer, Atte Nikkilä, Buddika Jayasingha, Artturi Mäkinen, Hassan Foroughi-Asl, Samuli Rounioja, Janne Suhonen, Olga Krali, Miikka Voutilainen, Mari Lahnalampi, Kaisa Vepsäläinen, Sui Huang, Jesus Duque-Afonso, Julia Hauer, Jessica Nordlund, Valtteri Wirta, Olli Lohi, and Merja Heinäniemi
Use of Histotripsy to Rapidly Relieve Biliary Obstruction in a Patient With Recurrent Hilar Cholangiocarcinoma., Evan S Ong, Chase J Wehrle, and Mohamed M Alassas
Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?, Javier I Orozco, Betsy Valdez, Emma S Trasatti, Sandy M Brown, Kimberly K Childers, Ora K Gordon, and Janie Grumley
Chronic Marijuana Use and Chronic Obstructive Pulmonary Disease: A Case Report., Brenna Ostertag, MD and Kathryn W Hendrickson
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group., Maxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Riccardo Autorino, Gabriele Bignante, Chandru Sundaram, Daniel Sidhom, Ithaar H Derweesh, Dhruv Puri, Vitaly Margulis, Benjamin Popokh, Firas Abdollah, Alex Stephens, Matteo Ferro, Giuseppe Simone, Gabriele Tuderti, Reza Mehrazin, Ahmed Eraky, Mark Gonzalgo, Omar Falik Nativ, Zhenjie Wu, Francesco Porpiglia, Enrico N Checcucci, Andres Correa, Randall Lee, Alessandro Antonelli, Alessandro Veccia, Soroush Rais-Bahrami, Alireza Dehghanmanshadi, Nirmish Singla, Stephan Brönimann, Sisto Perdonà, Roberto Contieri, Takashi Yoshida, James Porter, Saum Ghodoussipour, Luca Lambertini, Andrea Minervini, and Hooman Djaladat
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies., Quchang Ouyang, Jordi Rodon, Yan Liang, Xinhong Wu, Qun Li, Lihua Song, Min Yan, Zhongsheng Tong, YunPeng Liu, Zev A Wainberg, Ying Wang, Cuizhi Geng, Susanna V Ulahannan, Guohua Yu, Manish R Sharma, Xiang Wang, Judy S Wang, Alexander Spira, Weihong Zhao, Rachel E Sanborn, Ying Cheng, Xian Wang, Gesha Liu, Yaling Li, Junyou Ge, Elliot Chartash, Omobolaji O Akala, and Yongmei Yin
Assessment of Functional Status of Human Leukocyte Antigen Class I Genes in Cancer Tissues in the Context of Personalized Neoantigen Peptide Vaccine Immunotherapy., Vijay G Padul, Nupur Biswas, Mini Gill, Jesus A Perez, Javier J Lopez, Santosh Kesari, and Shashanka Ashili
Analysis of Endoscope-Assisted Retrosigmoid Approach versus Modified Transjugular Approach for Microvascular Decompression of the Facial Nerve: A Comparative Cadaveric Study., Mehrdad Pahlevani, Felipe Sfeir, Fan Zhao, Kayla Lanker, Alex Corlin, Regin Jay Mallari, Gregory Lekovic, and Garni Barkhoudarian
The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy., David J Park, Min Thura, Vi K Chiu, Brian Vicuna, Koon Hwee Ang, Blanca Sanchez, Pei Ling Chia, Kam Yew Kuan, Jie Li, Ke Zhang, Wei Hui Zheng, Matthew Chau Hsien Ng, and Qi Zeng
Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial., Jong Chul Park, Brendan Curti, Marcus Butler, Eric Wehrenberg-Klee, Joseph Elassal, Robert Tighe, Sailaja Battula, Gail Iodice, Howard L Kaufman, and John M Kirkwood
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update., Ko Un Park, Mark R Somerfield, Nirupama Anne, Muriel Brackstone, Alison K Conlin, Henrique Lima Couto, Lynn T Dengel, Andrea Eisen, Brittany E Harvey, Jeffrey Hawley, Janice N Kim, Nwamaka Lasebikan, Elizabeth S McDonald, Deepti Pradhan, Samantha Shams, Raymond Mailhot Vega, Alastair M Thompson, and Mylin A Torres
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study., Kelly G Paulson, Sally C M Lau, Myung-Ju Ahn, Mor Moskovitz, Michael Pogorzelski, Simon Häfliger, Amanda Parkes, Yuyang Zhang, Ali Hamidi, Corbin G Thompson, and Martin Wermke
Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy., Kelly G Paulson, Song Y Park, Shailender Bhatia, Daniel S Hippe, and Paul Nghiem
Evidence Based Research Review of Remote Independent Chemotherapy/Immunotherapy Verification, Katrina Perkins, Hannah Holder, and Marie St. Clair
Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trial., Tycel Phillips, Michael Wang, Tadeusz Robak, David Gallinson, Don Stevens, Krish Patel, Safaa Ramadan, Chuan-Chuan Wun, Wojciech Jurczak, and Stephen D Smith
Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomas., David Piccioni, Tiffany M Juarez, Sneha L Kesari, Lara Rose, Natsuko Nomura, and Santosh Kesari
Head and Neck Cancer Research Training Program Associated with Academic Success for Trainees., Aanish Puri, Andrew C Elton, Beverly R Wuertz, and Frank G Ondrey
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With, Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan, Crystal S Denlinger, Marwan Fakih, Michael J Overman, N Arvind Dasari, Larry R Corum, Lee G Hicks, Mital S Patel, Benjamin T Esparaz, Syed M Kazmi, Nitya Alluri, Sarah Colby, Sepideh Gholami, Philip J Gold, E Gabriela Chiorean, Scott Kopetz, Howard S Hochster, and Philip A Philip
Multimodal evaluation of cerebrospinal fluid from breast cancer leptomeningeal metastases using circulating tumor cell detection, single-cell sequencing, and proteomics., Elnaz Rahbarlayegh, Alexandre Wojcinski, Natsuko Nomura, Tiffany Juarez, Barbara Blouw, and Santosh Kesari
Biomarker-guided dose selection in the iintune-1 study of dazostinag,a STING agonist, alone and in combination with pembrolizumab for patients with metastatic solid tumors, R Ramesh, Rachel Sanborn, and See full list of authors in comments
Adoption of Single-Port Robotic Partial Nephrectomy Increases Utilization of the Retroperitoneal Approach: A Report from the Single-Port Advanced Research Consortium., Michael Raver, Mutahar Ahmed, Kennedy E Okhawere, Indu Saini, Ruchir Chaturvedi, Milan Patel, Ruben Sauer Calvo, Nicolas A Soputro, Roxana Ramos, Mubashir Billah, Simone Crivellaro, Ahmed M Mansour, Jihad Kaouk, Nirmish Singla, James Porter, Ronney Abaza, Akshay Bhandari, Ashok K Hemal, Phillip M Pierorazio, Benjamin I Chung, Craig G Rogers, Reza Mehrazin, Ketan Badani, and Michael Stifelman
Treatment of NSCLC after chemoimmunotherapy - are we making headway?, Martin Reck, Nikolaj Frost, Solange Peters, Bernard A Fox, Roberto Ferrara, Rajkumar Savai, and Fabrice Barlesi
AAPM medical physics practice guideline 13.a: HDR brachytherapy, part B., Susan L Richardson, Arjit K Baghwala, Gil'ad N Cohen, Claire Dempsey, Bruce Libby, Christopher S Melhus, Robin A Miller, Daniel J Scanderbeg, and Samantha J Simiele
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report., Gregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, Ibiayi Dagogo-Jack, Raymond Esper, Enriqueta Felip, Francesco Gelsomino, Jonathan W Goldman, Maen Hussein, Melissa Johnson, Kristen A Marrone, Daniel Morgensztern, Ernest Nadal, Marcelo V Negrao, Michael Offin, Mariano Provencio, Suresh S Ramalingam, Logan Roof, Rachel E Sanborn, Egbert F Smit, Anne Tsao, Tiziana Usari, Ann Alcasid, Keith Wilner, Svitlana Tonkovyd, Xiaosong Zhang, and Bruce E Johnson
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities: Proceedings from a conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City, May 22-23, 2025., Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou-Zeid, Vanderlei Bagnato, Christian Brandts, Chien-Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, and Nils Wilking
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)., Brian I Rini, Ana F Best, Mel D Bowman, Grace E Mishkin, Andrea M Denicoff, Larry V Rubinstein, Lyndsay Harris, Ann M Geiger, Nicholas M Mark, Steven A Pergam, Jeremy L Warner, Alok A Khorana, Sacha Gnjatic, Tina W F Yen, Darla K Liles, Christine M Bestvina, Neil J Shah, Jacqueline T Norrell, Dawn L Hershman, Jennifer L Holter-Chakrabarty, Andrew S Poklepovic, Stephen J Chanock, Hari Sankaran, and Larissa A Korde
